“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Novo Nordisk's high dose Wegovy (semaglutide) has shown improved weight loss while remaining safe and tolerable.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

According to NVO, the 7.2 mg version was safe and had a well-tolerated profile ... in addition to the health benefits already established with Wegovy,” said Martin Holst Lange, NVO’s executive ...

While it's illegal to sell certain substances without a prescription, it's possible that you could be sold fake weight loss ...

International Community Health Services (ICHS) has launched Together We Rise, a wellness podcast with useful information ...

The late-stage trial of semaglutide, which it markets as Wegovy to treat obesity ... the higher dose appeared to have a safe and well-tolerated profile, consistent with other drugs of the same ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

Weight-loss drugs such as Ozempic and Wegovy are increasingly popular among ... said research shows GLP-1s can be both effective and safe for kids and teens, but that research only shows the ...